Auflistung nach Autor "Nelde, Annika"

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Heitmann, Jonas S.; Bilich, Tatjana; Tandler, Claudia; Nelde, Annika; Maringer, Yacine; Marconato, Maddalena; Reusch, Julia; Jäger, Simon U.; Denk, Monika; Richter, Marion; Anton, Leonard; Weber, Lisa Marie; Rörden, Malte; Bauer, Jens; Rieth, Jonas; Wacker, Marcel; Hörber, Sebastian; Peter, Andreas; Meisner, Christoph; Fischer, Imma; Löffler, Markus W.; Klein, Reinhild; Rammensee, Hans-Georg; Salih, Helmut R.; Walz, Juliane S. (2022)

AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

Jung, Susanne; Nelde, Annika; Maringer, Yacine; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Martus, Peter; Hackenbruch, Christopher; Englisch, Alexander; Heitmann, Jonas S.; Salih, Helmut R.; Walz, Juliane S.; Oezbek, Melek T. (2024)

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants

Junker, Daniel; Becker, Matthias; Wagner, Teresa R.; Kaiser, Philipp D.; Maier, Sandra; Grimm, Tanja M.; Marsall, Patrick; Gruber, Jens; Heinzel, Constanze; Pinilla, Yudi T.; Held, Jana; Fendel, Rolf; Kreidenweiss, Andrea; Nelde, Annika; Maringer, Yacine; Walz, Juliane S.; Althaus, Karina; Mikus, Marco; Bakchoul, Tamam; Schenke-Layland, Katja; Bunk, Stefanie; Bitzer, Michael; Renk, Hanna; Remppis, Jonathan; Engel, Corinna; Zeck, Anne; Rothbauer, Ulrich; Dulovic, Alex; Schneiderhan-Marra, Nicole; Griesbaum, Johanna-Marie; Tränkle, Björn; Schröder, Sarah Marena; Uzun, Günalp; Häberle, Helene; Göpel, Siri; Franz, Axel Rainer (2023)

Antigen Targets for the Development of Immunotherapies in Leukemia

Bauer, Jens; Nelde, Annika; Bilich, Tatjana; Walz, Juliane S. (2019)

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo

Nelde, Annika; Schuster, Heiko; Walz, Juliane S. (2020)

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

Rammensee, Hans-Georg; Heidu, Sonja; Klein, Reinhild; Walz, Juliane S.; Nelde, Annika; Haen, Sebastian P.; Tabatabai, Ghazaleh; Hoffmann, Helen; Schindler, Michael; Planz, Oliver; Gouttefangeas, Cécile; Preuß, Beate; Bösmüller, Hans; Löffler, Markus W. (2021)

Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination

Maringer, Yacine; Nelde, Annika; Schröder, Sarah Marena; Schuhmacher, Juliane; Hörber, Sebastian; Peter, Andreas; Walz, Juliane S. (2022)

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

Hackenbruch, Christopher; Maringer, Yacine; Tegeler, Christian M.; Walz, Juliane S.; Nelde, Annika; Heitmann, Jonas S. (2023)

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity

Becker, Matthias; Junker, Daniel; Kaiser, Philipp D.; Dinter, Heiko; Häring, Julia; Zeck, Anne; Weise, Frank; Peter, Andreas; Fink, Simon; Schäfer-Ruoff, Felix; Bakchoul, Tamam; Rammensee, Hans-Georg; Schenke-Layland, Katja; Nelde, Annika; Heitmann, Jonas S.; Joos, Thomas; Rothbauer, Ulrich; Schneiderhan-Marra, Nicole; Tränkle, Björn; Hörber, Sebastian; Dulovic, Alex; Märklin, Melanie; Walz, Juliane S.; Templin, Markus F. (2021)

Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome

Salih, Helmut R.; Klein, Reinhild; Rammensee, Hans-Georg; Nelde, Annika; Rörden, Malte; Märklin, Melanie; Bethge, Wolfgang Andreas; Walz, Juliane S. (2021)

Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers

Walz, Juliane S.; Kowalewski, Daniel Johannes; Backert, Linus; Nelde, Annika; Kohlbacher, Oliver; Kanz, Lothar; Salih, Helmut R.; Rammensee, Hans-Georg; Stevanović, Stefan; Weide, Benjamin Matthias (2018)

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Hackenbruch, Christopher; Bauer, Jens; Heitmann, Jonas S.; Maringer, Yacine; Nelde, Annika; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Federmann, Birgit; Jung, Susanne; Martus, Peter; Nikolaou, Konstantin; Salih, Helmut R.; Bitzer, Michael; Walz, Juliane S.; Malek, Nisar Peter (2024)

HIV-1 induced changes in HLA-CM*03: 04-presented peptide repertoires lead to reduced engagement of inhibitory natural killer cell receptors

Nelde, Annika; Schreitmüller, Christian Marius; Stevanović, Stefan (2020)

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy

Nelde, Annika; Walz, Juliane S.; Kowalewski, Daniel Johannes; Schuster, Heiko; Wolz, Olaf-Oliver; Peper, Janet Kerstin; Cardona Gloria, Yamel; Bonzheim, Irina; Fend, Falko; Salih, Helmut R.; Kanz, Lothar; Rammensee, Hans-Georg; Weber, Alexander N. R.; Stevanović, Stefan (2017)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation

Nelde, Annika; Heitmann, Jonas S.; Klein, Reinhild; Rammensee, Hans-Georg; Rörden, Malte; Bethge, Wolfgang Andreas; Walz, Juliane S. (2020)

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Nelde, Annika; Backert, Linus; Schuster, Heiko; Werner, Jan-Ole; Klein, Reinhild; Kohlbacher, Oliver; Kanz, Lothar; Rammensee, Hans-Georg; Stevanović, Stefan; Kowalewski, Daniel Johannes; Salih, Helmut R.; Walz, Juliane S. (2018)

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients

Tegeler, Christian M.; Scheid, Jonas; Rammensee, Hans-Georg; Salih, Helmut R.; Walz, Juliane S.; Heitmann, Jonas S.; Nelde, Annika (2022)

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models

Lübke, Maren; Spalt, Stefanie; Kowalewski, Daniel Johannes; Nelde, Annika; Bichmann, Leon; Marcu, Ana; Peper, Janet Kerstin; Kohlbacher, Oliver; Walz, Juliane S.; Rammensee, Hans-Georg; Stevanović, Stefan (2020)

Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A*03 and HLA-B*15 via peptide-PRISM

Nelde, Annika; Lübke, Maren (2024)

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome

Marconato, Maddalena; Maringer, Yacine; Walz, Juliane S.; Nelde, Annika; Heitmann, Jonas S. (2022)

Auflistung nach Autor "Nelde, Annika"

Auflistung nach Autor "Nelde, Annika"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos